These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 24374123

  • 1. Extract of Cassiae semen attenuates diabetic nephropathy via inhibition of advanced glycation end products accumulation in streptozotocin-induced diabetic rats.
    Kim YS, Jung DH, Sohn E, Lee YM, Kim CS, Kim JS.
    Phytomedicine; 2014 Apr 15; 21(5):734-9. PubMed ID: 24374123
    [Abstract] [Full Text] [Related]

  • 2. Extract of Cassiae Semen and its major compound inhibit S100b-induced TGF-beta1 and fibronectin expression in mouse glomerular mesangial cells.
    Jung DH, Kim YS, Kim NH, Lee J, Jang DS, Kim JS.
    Eur J Pharmacol; 2010 Sep 01; 641(1):7-14. PubMed ID: 20483351
    [Abstract] [Full Text] [Related]

  • 3. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH, Feng L, Zhu MM, Gu JF, Jiang J, Cheng XD, Ding SM, Wu C, Jia XB.
    J Ethnopharmacol; 2014 Sep 01; 151(1):591-600. PubMed ID: 24269777
    [Abstract] [Full Text] [Related]

  • 4. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
    Liu IM, Tzeng TF, Liou SS, Chang CJ.
    J Ethnopharmacol; 2009 Jul 15; 124(2):211-8. PubMed ID: 19397971
    [Abstract] [Full Text] [Related]

  • 5. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS, Kim NH, Lee SW, Lee YM, Jang DS, Kim JS.
    Eur J Pharmacol; 2007 Aug 27; 569(3):171-9. PubMed ID: 17597607
    [Abstract] [Full Text] [Related]

  • 6. DW1029M, a novel botanical drug candidate, inhibits advanced glycation end-product formation, rat lens aldose reductase activity, and TGF-β1 signaling.
    Yoon J, Lee H, Chang HB, Choi H, Kim YS, Rho YK, Seong S, Choi DH, Park D, Ku B.
    Am J Physiol Renal Physiol; 2014 May 15; 306(10):F1161-70. PubMed ID: 24694590
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of oxymatrine on experimental diabetic nephropathy.
    Guo C, Han F, Zhang C, Xiao W, Yang Z.
    Planta Med; 2014 Mar 15; 80(4):269-76. PubMed ID: 24535719
    [Abstract] [Full Text] [Related]

  • 8. Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats.
    Sohn E, Kim J, Kim CS, Kim YS, Jang DS, Kim JS.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):733-8. PubMed ID: 19944074
    [Abstract] [Full Text] [Related]

  • 9. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy.
    Lee SH, Kim YS, Lee SJ, Lee BC.
    J Ethnopharmacol; 2011 Oct 11; 137(3):1409-14. PubMed ID: 21856399
    [Abstract] [Full Text] [Related]

  • 10. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats.
    Liu IM, Tzeng TF, Liou SS, Chang CJ.
    J Food Sci; 2011 Sep 11; 76(7):H165-74. PubMed ID: 22417553
    [Abstract] [Full Text] [Related]

  • 11. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats.
    Hao HH, Shao ZM, Tang DQ, Lu Q, Chen X, Yin XX, Wu J, Chen H.
    Life Sci; 2012 Nov 02; 91(19-20):959-67. PubMed ID: 23000098
    [Abstract] [Full Text] [Related]

  • 12. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
    Huang H, Jiang Y, Mao G, Yuan F, Zheng H, Ruan Y, Wu T.
    J Sci Food Agric; 2017 Mar 02; 97(4):1359-1366. PubMed ID: 27363537
    [Abstract] [Full Text] [Related]

  • 13. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS, Jung DH, Lee IS, Pyun BJ, Kim JS.
    Phytomedicine; 2016 Apr 15; 23(4):388-97. PubMed ID: 27002409
    [Abstract] [Full Text] [Related]

  • 14. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice.
    Lee AS, Lee YJ, Lee SM, Yoon JJ, Kim JS, Kang DG, Lee HS.
    Am J Chin Med; 2012 Apr 15; 40(3):495-510. PubMed ID: 22745066
    [Abstract] [Full Text] [Related]

  • 15. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI, Stanca L, Geicu OI, Munteanu MC, Costache M, Dinischiotu A.
    J Diabetes; 2015 Jan 15; 7(1):114-24. PubMed ID: 24666836
    [Abstract] [Full Text] [Related]

  • 16. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
    Hirasawa Y, Sakai T, Ito M, Yoshimura H, Feng Y, Nagamatsu T.
    Eur J Pharmacol; 2011 Dec 15; 672(1-3):159-68. PubMed ID: 21989075
    [Abstract] [Full Text] [Related]

  • 17. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
    Zuo Y, Gu Y, Ma J, Lin S.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 25; 82(4):239-43. PubMed ID: 11953170
    [Abstract] [Full Text] [Related]

  • 18. Anti-diabetic and renoprotective effects of Cassiae Semen extract in the streptozotocin-induced diabetic rats.
    Wang Q, Zhou J, Xiang Z, Tong Q, Pan J, Wan L, Chen J.
    J Ethnopharmacol; 2019 Jul 15; 239():111904. PubMed ID: 31022564
    [Abstract] [Full Text] [Related]

  • 19. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
    Liu K, Xu H, Lv G, Liu B, Lee MK, Lu C, Lv X, Wu Y.
    Life Sci; 2015 Feb 15; 123():78-85. PubMed ID: 25623853
    [Abstract] [Full Text] [Related]

  • 20. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y, Lin S, Zhou J.
    Chin Med J (Engl); 1998 Aug 15; 111(8):698-704. PubMed ID: 11245022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.